We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00401011
Recruitment Status : Completed
First Posted : November 17, 2006
Last Update Posted : February 23, 2018
Information provided by (Responsible Party):
AEterna Zentaris